| Share on Facebook Facebook | Share on StumbleUpon StumbleUpon |
| Share on LinkedIn LinkedIn | Submit on Reddit reddit |
| Tweet Twitter | Pin it Pinterest |
| Share on Google+ Google+ | Share on Digg Digg |
| Post to Tumblr Tumblr | Share on Delicious Delicious |
-
VanEck Blog - Emerging Markets Equity
Emerging Markets EquityJuly 14, 2020
Stimulus and Easing Restrictions Accelerate Growth
David Semple, Portfolio Manager, Emerging Markets Equity Strategy
Oksana Miller , Product Manager
Accelerated consumption trends in industries such as healthcare, e-commerce and education make these the most attractive opportunities across emerging markets in our view.
Emerging Markets EquityJune 22, 2020
Emerging Markets vs. Developed: Where to Invest Now?
by David Semple, Portfolio Manager, Emerging Markets Equity Strategy,
Oksana Miller , Product Manager
Read moreIn the ongoing debate between emerging markets vs. developed, we examine growth drivers and valuations to assess which is more compelling for global investors now and why.
Emerging Markets EquityMay 14, 2020
Facebook & Leading U.S. Venture Capital Firms Round out Reliance Industries’ Ecommerce Ambitions
by Angus Shillington, Deputy Portfolio Manager,
David Semple, Portfolio Manager, Emerging Markets Equity Strategy,
Oksana Miller , Product Manager
Read moreEmerging markets companies like Reliance Industries are front and center in digital disruption, and recent investments in the company play neatly into our original thesis.
Emerging Markets EquityApril 15, 2020
Looking Beyond COVID-19: Investing in the Future of Emerging Markets Today
by David Semple, Portfolio Manager, Emerging Markets Equity Strategy,
Oksana Miller , Product Manager
Read moreAlong with forward-looking business models, exceptional structural growth companies tend to have robust balance sheets, which may help them weather this storm and take advantage of opportunities as clouds lift.
Emerging Markets EquityMarch 24, 2020
Harnessing Growth: WuXi Biologics and the Race for a COVID-19 Vaccine
by Dominic Jacobson, Analyst,
David Semple, Portfolio Manager, Emerging Markets Equity Strategy
Read moreWuXi Biologics, a leading Chinese healthcare name, is an example of how pockets of alpha can be found where companies are providing solutions to problems caused by the novel coronavirus outbreak.